|
|
TTD Drug ID:
DNC007814
Drug
Information |
Name | 1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C9H12F5NS/c1-7(15)5-8-3-2-4-9(6-8)16(10,11,12,13)14/h2-4,6-7H, 5,15H2,1H3 | InChIKey | YGBSUVPUXAMOTQ-UHFFFAOYSA-N | Canonical SMILES | CC(CC1=CC(=CC=C1)S(F)(F)(F)(F)F)N | Target | Serotonin 1a (5-HT1a) receptor |  | Inhibitor | [1] | Serotonin 1b (5-HT1b) receptor |  | Inhibitor | [1] | Serotonin 1d (5-HT1d) receptor |  | Inhibitor | [1] | Serotonin 2a (5-HT2a) receptor |  | Inhibitor | [1] | Serotonin 2b (5-HT2b) receptor |  | Inhibitor | [1] | Serotonin 6 (5-HT6) receptor |  | Inhibitor | [1] | Serotonin 7 (5-HT7) receptor |  | Inhibitor | [1] | Ref 1 | Bioorg Med Chem. 2007 Nov 1;15(21):6659-66. Epub 2007 Aug 15.The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|